The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 205
Publisher
MDPI AG
Online
2020-01-15
DOI
10.3390/cancers12010205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling
- (2019) Felicitas Bossler et al. mBio
- PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells
- (2019) Felicitas Bossler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual Targeting of Y-Box Binding Protein-1 and Akt Inhibits Proliferation and Enhances the Chemosensitivity of Colorectal Cancer Cells
- (2019) Maier et al. Cancers
- RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells
- (2018) Margie N. Sutton et al. Autophagy
- Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway
- (2018) Suxian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer
- (2018) Rong Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway
- (2018) Chunxiu Dai et al. BIOMEDICINE & PHARMACOTHERAPY
- HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner
- (2018) Tatiana Rabachini et al. BMC CANCER
- Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis
- (2018) Xuejing Jin et al. GENE
- γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway
- (2018) Yanli Li et al. GYNECOLOGIC ONCOLOGY
- MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
- (2018) Fang Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach
- (2018) Veena B. Nair et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR
- (2018) Yuping Du et al. MOLECULAR CARCINOGENESIS
- PERK/eIF2α signaling inhibits HIF-induced gene expression during the unfolded protein response via YB1-dependent regulation of HIF1α translation
- (2018) Iglika G Ivanova et al. NUCLEIC ACIDS RESEARCH
- Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes
- (2018) Raphael Hohlfeld et al. Oncotarget
- Cold shock proteins: from cellular mechanisms to pathophysiology and disease
- (2018) Jonathan A. Lindquist et al. Cell Communication and Signaling
- Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer
- (2018) Chang Liu et al. Frontiers in Genetics
- LncRNAs in ovarian cancer
- (2018) Jin-yan Wang et al. CLINICA CHIMICA ACTA
- Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail
- (2017) Tianyun Pang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro
- (2017) Masakazu Sato et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression
- (2017) Li-Li Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer
- (2017) Ying Zeng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control
- (2017) Mariana Lopes Grassi et al. Journal of Proteomics
- Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
- (2017) Subhransu S. Sahoo et al. MOLECULAR CANCER RESEARCH
- A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
- (2017) Andréia Cristina de Melo et al. Oxidative Medicine and Cellular Longevity
- miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
- (2017) Zhihong Zhuo et al. Oncotarget
- Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3
- (2017) Yin-ling Xiu et al. Oncotarget
- Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells
- (2017) Ke-yan Cheng et al. MEDICAL SCIENCE MONITOR
- MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR
- (2017) Suxia Zhang et al. Cancer Biomarkers
- A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding
- (2016) Jodie N. Painter et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data
- (2016) Loay Kassem et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)
- (2016) Irena Rohr et al. CYTOKINE
- Genetic alterations in endometrial cancer by targeted next-generation sequencing
- (2016) Ya-Sian Chang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN
- (2016) David A. Iglesias et al. ONCOLOGY
- Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
- (2016) YAPING ZHU et al. ONCOLOGY REPORTS
- Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer
- (2016) Runmin Wei et al. Oncotarget
- Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
- (2016) Natividad Gomez-Roman et al. Oncotarget
- Selective regulation of YB-1 mRNA translation by the mTOR signaling pathway is not mediated by 4E-binding protein
- (2016) D. N. Lyabin et al. Scientific Reports
- Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
- (2015) Jianjun Han et al. GYNECOLOGIC ONCOLOGY
- Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1α Accumulation in Cancer Cells
- (2015) Hyunju Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
- (2015) Lifang Zhang et al. Molecular Cancer
- Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression
- (2015) C Duckworth et al. ONCOGENE
- MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells
- (2015) Jianglin Cong et al. Artificial Cells Nanomedicine and Biotechnology
- mTOR signaling in tumorigenesis
- (2014) Kai Xu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser167in endometrioid endometrial cancer
- (2014) Eiichi Kato et al. CANCER SCIENCE
- Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer
- (2014) Shin Nishio et al. GYNECOLOGIC ONCOLOGY
- mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway
- (2014) Li Wang et al. MEDICAL ONCOLOGY
- Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
- (2014) Stefanie Aust et al. Molecular Cancer
- Molecular regulation of cervical cancer growth and invasion by VEGFa
- (2014) Baohuan Chen et al. TUMOR BIOLOGY
- Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway
- (2013) Gang Wan et al. Autophagy
- Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer
- (2013) Helen J. Mackay et al. CANCER
- Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models
- (2013) Joseph M. Gozgit et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
- (2013) Emmanuelle Roche et al. CELLULAR SIGNALLING
- MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR)
- (2013) Dong Wu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Absence of Human Papillomavirus Infection and Activation of PI3K-AKT Pathway in Cervical Clear Cell Carcinoma
- (2013) Sayaka Ueno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Targeting Signaling Pathways in Epithelial Ovarian Cancer
- (2013) Elisabeth Smolle et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
- (2013) Zachary Dobbin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis
- (2013) Pengda Liu et al. NATURE CELL BIOLOGY
- Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells
- (2013) Kavita S. Subramaniam et al. PLoS One
- microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
- (2013) ZHONGXIAN WANG et al. Oncology Letters
- Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion
- (2012) Samantha E. Griner et al. BIOCHEMICAL PHARMACOLOGY
- Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
- (2012) Anna Torres et al. BMC CANCER
- The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells
- (2012) Man-Tat Lau et al. CANCER LETTERS
- Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer
- (2012) Ivan Diaz-Padilla et al. CANCER TREATMENT REVIEWS
- A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS
- (2012) Mako Narisawa-Saito et al. CARCINOGENESIS
- mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
- (2012) A. A. Molinolo et al. CLINICAL CANCER RESEARCH
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications
- (2012) Juan Carlos Montero et al. MOLECULAR CANCER THERAPEUTICS
- CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells
- (2011) Kwang-Beom Lee et al. CANCER LETTERS
- miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer
- (2011) T. Tsuruta et al. CANCER RESEARCH
- Cold-shock domain family member YB-1 expression in endometrium and endometriosis
- (2011) C. G. T. Silveira et al. HUMAN REPRODUCTION
- Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
- (2011) Y. Zhang et al. MEDICAL ONCOLOGY
- Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells
- (2011) Y Wang et al. ONCOGENE
- Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer
- (2010) Yoshio Yoshida et al. EUROPEAN JOURNAL OF CANCER
- Activation of mTOR signaling pathway contributes to survival of cervical cancer cells
- (2010) Jing Ji et al. GYNECOLOGIC ONCOLOGY
- A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
- (2010) Ankur K. Nagaraja et al. MOLECULAR ENDOCRINOLOGY
- The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
- (2009) X B Trinh et al. BRITISH JOURNAL OF CANCER
- Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer
- (2009) Hai-Yan Zhang et al. CANCER LETTERS
- Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer
- (2008) Xiao-Yan Zhang et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro
- (2008) Silvia Darb-Esfahani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now